Market access experts accelerate entry into Europe's neurological drugs market

Discover how a healthcare consultancy used insights gained from experts sourced by Techspert to help their end client launch their neurological drugs portfolio in Europe.

The challenge

A healthcare strategy consultancy conducting market research needed us to connect them with senior market access experts experienced in the pricing or reimbursement of neurological drugs or drug/device combinations to help their end client enter the European market.

As such, the customer requested market access specialists experienced with the EU5 (France, Germany, Italy, Spain, and the UK), Luxembourg, Belgium or the Netherlands markets and they wanted to begin interviews the next day.

The solution

Our customers need insights fast and they need them from today’s experts, not yesterday’s. That’s why we put a lot of effort into ensuring that our AI search technology sources the right experts swiftly.

We sourced, vetted, and scheduled interviews with market access experts across Europe experienced in the pricing or reimbursement of neurological drugs within a week of the customer sending their requirement. Our ability to rapidly deliver precision-matched, world-leading experts is because of our internal Knowledge Graph.

Once our AI has scoured the web to extract useful expert profiles, the Knowledge Graph takes this data and creates a visualization showing the relationships between experts, institutions, online media, and semantic concepts.

Based on the criteria we’ve set (such as qualifications, experience, and citations), it also ranks experts amongst their peers to identify the key thought-leaders in the field.

An example of a knowledge graph showing links between experts, organizations, universities and publications.

The outcome

After identifying the market access experts, we scheduled the 60-minute qualitative interviews between them and the customer. These interactions enabled our customer and their end client to develop a deeper understanding of the European neurological drugs market and how to enter it successfully.

The market access experts the customer gained insights from included:

A Neurology Business Manager at a global biotechnology company with 30 years’ experience in pharmaceutical sales	A Head of Market Access at an international pharmaceutical company with more than 20 years’ experience.	A Neurology PVU (Patient Value Unit) International Markets Team Lead at a global biopharmaceutical company.